Latest news with #Eternia
Time of India
3 days ago
- Health
- Time of India
Uptick in Covid cases, symptoms mostly mild
Pune: Several city hospitals are of late reporting an uptick in Covid-19 patients, most with mild symptoms. Dr Piyush Chaudhary, an infectious disease specialist at Jehangir Hospital, confirmed the uptick in cases. "The number of cases being detected is definitely increasing, but predominantly they are milder. Only patients who are elderly or have comorbidities with multiple medical problems are experiencing severe disease," he said. The hospital currently has two Covid patients in the ICU, both elderly individuals aged 75-80 years with multiple underlying health conditions. Healthcare professionals are observing a growing demand for precautionary vaccine doses amid increase in Covid cases. Reasons: Patients' immunity from last shots in 2022 has begun to wane and current variants differ from those the earlier vaccines were designed to combat. Most new cases are being attributed to the Omicron sub-variant JN.1. Other strains, including NB 1.8.1 and LF.7, are also under observation, according to recent reports. Dr Chaudhary said, "The increase in Covid cases has been noticeable over the last two weeks, with more cases appearing this week. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Eternia Spacious 3 & 4 BHK Residences for Grand Living Eternia Residences Learn More Undo It's gradually increasing." He attributed part of the rise in detected cases to increased testing. "Now that Covid is everywhere in the news, people are testing more," Dr Chaudhary said. "While there is increased interest from patients regarding vaccination, Covid vaccines are currently not available in the market. The vaccines we previously administered offer some protection against severe disease, though they were formulated for earlier variants. An updated vaccine would help boost antibody response and provide enhanced protection against current strains," he said. Dr Ameet Dravid, an infectious diseases expert with Noble Hospital, said, "There's a definite uptick in Covid cases. This week we've had around six cases, with the majority seen in the outpatient department. Two patients are currently admitted in the ICU." He said, "One is 25-year-old, who developed seizures after having fever for two days and tested positive for Covid. The second is a 70-year-old woman, who came with breathlessness. We initially thought it was heart-related, but her Covid test also came positive. Both ICU patients are recovering." Dr Dravid, "Swab samples of the patients have gone to NIV, and only those confirmed by it will be part of government Covid data statistics. The actual number of cases is likely to be much higher because private labs are testing but government reporting only includes NIV-confirmed samples." He said there had been an uptick in upper respiratory tract illnesses, with some turning out to be Covid. The majority were H1N1 or swine flu, though. Dr Ajit Tambolkar, intensivist at Poona Hospital, said, "We have a Covid patient, a 70-year-old diabetic man, in the isolation ward. He doesn't require ICU care. Another was discharged recently — a young girl with no comorbidities but had recent travel history. She has been discharged. The 70-year-old man initially needed oxygen, which was stopped on Friday. These cases came in the last seven days. We had no Covid cases before that. Symptoms are mild — cough, cold, fever and flu-like symptoms. We suggest people seek medical intervention if their symptoms last for more than three days." Dr Nikhil Phadke, founder-director and chief science officer of GenePath Diagnostics, said "We have started seeing Covid positives again after a long time in the past 10 days. But the uptick doesn't seem dramatic so far." A senior state health department official said, "No Covid vaccine is available currently because manufacturing stopped due to reduced demand in the past. The latest uptick in Covid cases is expected as it's endemic, and we have more H1N1 cases than Covid at present. Vaccination is a preventive policy when infections are on a large scale. According to public health experts, Covid vaccination is not required currently as it is endemic and the number of such cases is within normal parameters. "
Business Standard
27-05-2025
- Business
- Business Standard
Aluwind Infra-Tech Limited Reports a 51.59% YoY Increase in Revenue, Reaching Rs 6,376.73 Lakhs in H2 FY25
PNN Mumbai (Maharashtra) [India], May 27: Aluwind Infra-Tech Limited, a specialised infrastructure solutions company providing end-to-end designing, fabrication, and application of windows and facade, announced its audited financial results for the H2 FY25 and financial year ending March 31, 2025. KEY FINANCIAL HIGHLIGHTS H2 FY25 (YoY Comparison): * Revenue: Rs 6,376.73 Lakhs | YoY Growth: 51.59% * EBITDA: Rs 834.71 Lakhs | YoY Growth: 37.63% * Profit After Tax: Rs 586.13 Lakhs | YoY Growth: 53.59% FY25 (YoY Comparison): * Revenue: Rs 10,922.48 Lakhs | YoY Growth: 30.92% * EBITDA: Rs 1,198.48 Lakhs | YoY Growth: 1.51% * Profit After Tax: Rs 812.13 Lakhs | YoY Growth: 7.64% Strategic & Operational Highlights * 35+ years of industry presence in facade and fenestration solutions. * Completed 300+ projects across 20+ cities with 85+ ongoing projects. * State-of-the-art facility in Pune, Maharashtra, spread over 75,000+ sq. ft, equipped with advanced machinery and quality control systems. * Received the India 500 SME Award in 2023 for excellence in quality, customer satisfaction, and societal impact. ORDER BOOK OF COMPANY AS ON DATE: Currently, the Company has a healthy order book of approximately INR 302 Crore, indicating strong demand and robust business momentum. This order will enhance revenue visibility for the upcoming years. INCORPORATION OF ALUWIND CLEAN-TECH PRIVATE LIMITED: In order to provide high-quality professional window cleaning solutions for a variety of clients, the company has incorporated a Subsidiary Company named Aluwind Clean Tech Private Limited. The Subsidiary Company will focus on undertaking Annual Maintenance Contracts (AMC) and service agreements for facade cleaning, exterior upkeep, and related maintenance services, ensuring periodic and comprehensive maintenance of buildings and infrastructure. ANCHOR PARTNER FOR MMR REGION (MUMBAI METROPOLITAN REGION) FOR ERTERNIA, HINDALCO INDUSTRIES LIMITED (ADITYA BIRLA GROUP). The Company is the Anchor Partner for the Mumbai Metropolitan Region (MMR) for Eternia, the premium aluminium windows and doors brand by Hindalco Industries Limited (Aditya Birla Group). This strategic partnership reinforces our position as a trusted leader in high-performance fenestration solutions and aligns with Eternia's mission to bring next-generation, sustainable aluminium window systems to the market. INNOVATION: The Company is using a patented cutting edge aluminium alloy named "Duranium" which is a trademark product of the Hindalco which have more strength and high finish exposure as compare to 6063-T6 alloy including corrosion resistance and a sleek, modern finish. Windows made out of Duranium offer superior window and noise protection INFORMATION ON NEW PLANT AND MACHINES: The Company has purchased a new 5X CNC Machine to increase production in the Aluminium segment. The new machine is equipped as standard with an advanced cutting unit for all the cutting needed for doors, windows, facades, HST sliding structures, or conservatories. This new machine leads to an increase in production capacity. FACILITY OF POWDER COATING FACILITY: The Company provides a fully automatic in-house powder coating facility, which leads to a significant step forward in the company's ongoing commitment to delivering high-quality surface finishes with improved speed, consistency, and sustainability. For Further Information, Please Contact the Corporate Communication Advisor * AKMIL Strategic Advisors Private Limited * Mr. Milind Apte - Director * milind@ * Disclaimer: Certain statements in this document that are not historical facts are forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.
